Albany, NY -- (SBWIRE) -- 10/25/2016 -- Uterine cancer is a cancer of uterus and is classified into the following four types, namely uterine sarcomas, endometrial cancer, cervical cancer and gestational trophoblastic disease. These cancers arise from malignancies of connective tissues, endometrium and cervix uteri of the uterus. Uterine cancers are the fourth most common cancers among women overall.

According to American Cancer Society (ACS), uterine sarcoma accounts for 5% of the total global uterine cancer cases whereas endometrial cancer is most prevalent form of uterine cancer. Both of these cancers can be diagnosed either by medical imaging techniques such as magnetic resonance imaging (MRI), ultrasound and CT scan or by histological examination of the tissues of uterus. Cervical cancer is one of the most common and fifth death-causing cancers in women.

Presence of cervical cancer can be checked with the help of endometrial biopsy, colposcopy or a screening test called as Pap smear. Radiation therapies can be applied to cure cervical cancer as it is radiosensitive. In the worst case of infection, surgical removal of the uterus called as hysterectomy, is performed. Surgery combined with radiation therapies is often used to treat endometrial cancer.

According to the surveys of World Health Organization (WHO), the prevalence of endometrial cancer is greater in the developed region such as the North American countries followed by European countries due to changing lifestyle of women. Prevalence of uterine cancer is more in women aged 50 years and above. The incidence of cervical cancer is greater in the developing countries such as India and China accounting for 80% of the total incidences.

Request Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1329

Some of the market players in this industry are Abbott Laboratories, Roche Ltd, Siemens Healthcare Inc. and Becton, Dickinson and Company.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com